| Clinical, echo features and fluoroscopic indexes |
Total N 45 |
| Age years ± SD |
72.6 ± 9 |
| Sex male n (%) |
28 (62.2) |
| PM n (%) |
27 (60) |
| ICDn (%) |
18 (40) |
| Baseline Paced QRS n (%) |
15 (31.2) |
| Permanent AFn (%) |
13 (28.9) |
| ACE or ARBn (%) |
45 (100) |
| BBn (%) |
43 (95.6) |
| DIURn (%) |
44 (97.8) |
| CADn (%) |
17 (37.8) |
| Prev Ant MIn (%) |
6 (13.3) |
| QRS durationms ± SD |
188.3 ± 19 |
| LBBB typicaln (%) |
22(48.9) |
| NYHA n ± SD |
2.5 ± 0.6 |
| RV apex leadn (%) |
42 (93.3) |
| EDV pre ml/m2 ± SD |
115.5 ± 40.3 |
| EDD premm ± SD |
66.2 ± 7.8 |
| LVEF pre % ± SD |
32.3 ± 7.4 |
| ESV preml/m2 ± SD |
79.3 ± 32 |
| MR /4 n ± SD |
1.6 ± 1 |
| TR /4n ± SD |
1.1 ± 1 |
| Follow up months ± SD |
12.3 ± 7.8 |
|
